SonoVue实时超声造影评价超声引导下肝癌介入治疗疗效  

Application of Real-time SonoVue-enhanced Ultrasonography in Assessing Ultrasound-guided Interventional Treatment Outcome of Hepatomas

作　　者：陈卉品[1] 张晓东[2] 李琦[1] 郭新华[1] 赵世怡[1] 

机构地区：[1]厦门大学附属中山医院B超室,福建省361004 [2]厦门市第一医院B超室

出　　处：《中国超声诊断杂志》2006年第9期657-659,共3页Chinese Journal of Ultrasound Diagnosis

摘　　要：目的探讨实时超声造影在肝癌超声引导介入治疗后局部疗效判断中的应用价值。方法对32例肝癌患者(39个病灶)在超声引导介入治疗后进行SonoVue实时超声造影和增强CT检查,以最终诊断为标准评价实时超声造影的准确性。结果39个病灶中实时超声造影检查显示14个病灶有残存活性,与增强CT检查结果相符,而常规彩超仅检出4例,敏感性和准确性明显低于实时超声造影。结论实时超声造影是一种评价肝癌超声介入治疗疗效的有效可靠方法。Objective To investigate the value of real-time contrast-enhanced ultrasonography in the assessment of the efficacy on ultrasound-guided intralesional treatment of hepatomas, Methods Thirty-two patients with 39 lesions submitted to ultrasound-guided intralesional treatment underwent both real-time SonoVue- enhanced ultrasonography and enhanced CT scan. The ultimate diagnosis were regarded as the standard in determining the efficacy of real-time contrast-enhanced ultrasonography. Results Ehancement were both detected in 14 lesions by real-time contrast-enhanced uhrasonography and enhanced CT scans, but 4 lesions by the routine color Doppler ultrasonography. The sensitivity and accuracy of the routine color-Doppler ultrasonography were obviously lower than those of the real-time contrast-enhanced ultrasonography. Conclusions Real-time contrast- enhanced ultrasonography may be an effective and reliable method for assessing ultrasound-guided intralesional treatment.

关 键 词：超声造影 肝癌 介入治疗 

分 类 号：R735.7[医药卫生—肿瘤] R981[医药卫生—临床医学]